Haitian Creole
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
nicotinamide/atrophy
Lyen an sove nan clipboard la
6 rezilta yo
Administration of nicotinamide mononucleotide in the treatment of disease
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
INTRODUCTION
Age-related obesity is a health-related problem for which new treatments and methods of ameliorating, mitigating, or reversing are needed. U.S. Pat. No. 8,268,575 to Imai, S., et al. asserts that "Chemical effectors for mammalian NAD biosynthesis can mediate a variety of anti-aging
Administration of nicotinamide mononucleotide in the treatment of disease
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
INTRODUCTION
Age-related obesity is a health-related problem for which new treatments and methods of ameliorating, mitigating, or reversing are needed. U.S. Pat. No. 8,268,575 to Imai, S., et al. asserts that "Chemical effectors for mammalian NAD biosynthesis can mediate a variety of anti-aging
Composition and methods for skin care
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD OF THE INVENTION
The present invention relates to compositions useful for effecting an improvement in the appearance and feel of skin. In particular, the present invention provides compositions comprising vitamin D.sub.3 or specific analogs thereof as an essential ingredient thereof, and in
Composition and method for treating conditions associated with symptoms of unspecified retarded maturation
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
In general, the patients included in this study had received different types of medication, without any positive results. The medication they received most was anticonvulsives and neuroleptics.
Some comments about other treatments are the following: in young patients
Pharmaceutical formulations and methods for treating patients suffering from diseases that cause muscular hypotonia
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD OF THE INVENTION
The present invention relates to the treatment of a variety of disorders which have in common the symptom of muscular hypotonia. More specifically, the invention pertains to the pharmaceutical treatment of such disorders, using a formulation of neurotransmitters, antioxidants,
Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed to methods for reducing the degree of neural degeneration in a mammal due to acute neural trauma by the administration of a NAD-related compound.
The methods of this invention are directed to the discovery that
Baz done ki pi konplè remèd fèy medsin te apiye nan syans
- Travay nan 55 lang
- Geri èrbal te apiye nan syans
- Remèd fèy rekonesans pa imaj
- Kat entèaktif GPS - tag zèb sou kote (vini byento)
- Li piblikasyon syantifik ki gen rapò ak rechèch ou an
- Search remèd fèy medsin pa efè yo
- Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive
Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye
